Cannabis could prevent the development of a fatty liver in HIV-HCV co-infected patients

Hepatitis C is found in those affected by a liver inflammation caused by the hepatitis C virus (HCV). The human immunodeficiency virus (HIV), on the other hand, is a virus that attacks the immune system of the affected person and can cause AIDS. Both HIV and hepatitis C can be transmitted by blood. Those who [...]

Clinical trials with Medicinal Cannabis for Inflammatory Bowel Disease

The term Inflammatory bowel disease (IBD) is used to describe two different conditions: Ulcerative colitis and Crohn's disease. Both are long-term conditions that cause chronic inflammation in the intestine that can result in severe damage to internal organs. While ulcerative colitis only affects the large intestine and anus, Crohn's disease can occur in any part [...]

Cannabibiol has been taken off the WADA Prohibited Substances List

The World Anti-Doping Agency (WADA) announced that from the 1st of January 2018 Cannabidiol will no longer be on the prohibited substances list. WADA was established in 1999 as an international independent agency that focuses their efforts on scientific research, education, developing anti-doping techniques as well as creating (in 2004) monitoring the World Anti-Doping Code [...]

CENTRAL OFFICE LOCATION

Kalapa Clinic S.L.
B66397506
Gran de Gràcia 15 , 1º.1ª
08012. Barcelona. Spain.
Tel: +34 630 109 176
Email: info@kalapa-clinic.com